Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States

BACKGROUND: Patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) have increased risks for cardiovascular (CV)-related morbidity and mortality. In the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) clinical trial of such patients, r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am Health Drug Benefits
Asıl Yazarlar: Hernandez, Luis, Shah, Anshul, Zhao, Qi, Milentijevic, Dejan, Kharat, Akshay
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Engage Healthcare Communications, LLC 2020
Konular:
Business
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7741174/
https://ncbi.nlm.nih.gov/pubmed/33343818
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller